Kite Pharma Inc (KITE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2017 | 03-2017 | 12-2016 | 09-2016 | 06-2016 | |
| Sales | 10,052 | 9,836 | 4,907 | 7,341 | 4,795 |
| Gross Profit | 10,052 | 9,836 | 4,907 | 7,341 | 4,795 |
| Operating Expenses | 111,971 | 101,748 | 90,897 | 82,294 | 71,069 |
| Operating Income | -101,919 | -91,912 | -85,990 | -74,953 | -66,274 |
| Interest Expense | 0 | 4 | -183 | 196 | 0 |
| Other Income | -1,144 | 1,456 | 560 | 911 | 920 |
| Pre-tax Income | -103,063 | -90,460 | -85,247 | -74,238 | -65,354 |
| Income Tax | 6,759 | -61 | -313 | -292 | -1,080 |
| Net Income Continuous | -109,822 | -90,399 | -84,934 | -73,946 | -64,274 |
| Net Income | $-109,822 | $-90,399 | $-84,934 | $-73,946 | $-64,274 |
| EPS Basic Total Ops | -1.94 | -1.74 | -1.76 | -1.49 | -1.31 |
| EPS Basic Continuous Ops | -1.94 | -1.74 | -1.76 | -1.49 | -1.31 |
| EPS Diluted Total Ops | -1.94 | -1.74 | -1.76 | -1.49 | -1.31 |
| EPS Diluted Continuous Ops | -1.94 | -1.74 | -1.76 | -1.49 | -1.31 |
| EPS Diluted Before Non-Recurring Items | -1.94 | -1.74 | -1.70 | -1.49 | -1.31 |
| EBITDA(a) | $-98,156 | $-88,347 | $-82,422 | $-71,624 | $-63,256 |